Literature DB >> 1325758

New aerosol delivery system for neonatal ventilator circuits.

M L Everard1, J Stammers, J G Hardy, A D Milner.   

Abstract

There is mounting evidence that a variety of drugs delivered as aerosols are likely to be of benefit in neonatal units. To avoid many of the problems associated with the use of jet nebulisers in ventilator circuits, a chamber was designed to be used in conjunction with a metered dose inhaler (MDI). The dimensions (4 cm x 11 cm) were chosen in an attempt to maximise drug delivery. In vitro studies were subsequently performed in order to determine the optimum operating conditions. Sodium cromoglycate delivered via this system was collected on a filter placed between the tip of an endotracheal tube and a model lung. The dose delivered was determined by means of an ultraviolet spectrophotometric assay. Using a Draeger Babylog 8000 ventilator it was found that drug delivery as maximised by actuating the device just before the inspiratory cycle when the chamber was placed adjacent to the endotracheal tube and by using a long (one second) inspiratory time. Under these conditions 1.5-2% of the original dose was deposited upon the filter at tidal volumes of 11-22 ml. When considered in terms of body weight this is many times the equivalent dose delivered to adults from an MDI. Effective drug delivery to the filter was confirmed using a radiolabelled aerosol. Radiolabelled studies delivering aerosol to the lungs of intubated rabbits demonstrated that deposition aerosol was distributed uniformly between lobes when corrected for the weight of each lobe. In conclusion, the device appears likely to deliver significant, reproducible quantities of drug to the lower respiratory tract while being simple to use.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325758      PMCID: PMC1590402          DOI: 10.1136/adc.67.7_spec_no.826

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

Review 1.  Aerosol therapy in the newborn.

Authors:  M Silverman
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

2.  Effects of inhaled metaproterenol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia.

Authors:  L C Kao; D J Durand; B G Nickerson
Journal:  Pediatr Pulmonol       Date:  1989

3.  Drug delivery from holding chambers with attached facemask.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

4.  Aerosol delivery in neonatal ventilator circuits: a rabbit lung model.

Authors:  D Cameron; R Arnot; M Clay; M Silverman
Journal:  Pediatr Pulmonol       Date:  1991

5.  Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study.

Authors:  T F Yeh; J A Torre; A Rastogi; M A Anyebuno; R S Pildes
Journal:  J Pediatr       Date:  1990-08       Impact factor: 4.406

6.  Delivery efficiency of metered dose aerosols given via endotracheal tubes.

Authors:  S J Crogan; M J Bishop
Journal:  Anesthesiology       Date:  1989-06       Impact factor: 7.892

7.  Aerosol delivery devices for the anesthesia circuit.

Authors:  G L Bush
Journal:  Anesthesiology       Date:  1986-08       Impact factor: 7.892

8.  Pressurized aerosol versus jet aerosol delivery to mechanically ventilated patients. Comparison of dose to the lungs.

Authors:  H D Fuller; M B Dolovich; G Posmituck; W W Pack; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1990-02

9.  Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients.

Authors:  P C Gay; H G Patel; S B Nelson; B Gilles; R D Hubmayr
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

10.  Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia.

Authors:  E K Motoyama; M D Fort; K W Klesh; R L Mutich; R D Guthrie
Journal:  Am Rev Respir Dis       Date:  1987-07
View more
  7 in total

Review 1.  Aerosol delivery to ventilated newborn infants: historical challenges and new directions.

Authors:  Jan Mazela; Richard A Polin
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

Review 2.  Nebuliser therapy in the intensive care unit.

Authors:  M J O'Doherty; S H Thomas
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  Studies using radiolabelled aerosols in children.

Authors:  M L Everard
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

4.  Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease.

Authors:  T F Fok; K Lam; P C Ng; H K So; K L Cheung; W Wong; K W So
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

5.  Optimal delivery of aerosols to infants during mechanical ventilation.

Authors:  P Worth Longest; Mandana Azimi; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-12-03       Impact factor: 2.849

6.  Therapeutic aerosols in children.

Authors:  S H Thomas; S Batchelor; M J O'Doherty
Journal:  BMJ       Date:  1993-07-24

7.  Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease.

Authors:  K A Jangaard; D A Stinson; A C Allen; M J Vincer
Journal:  Paediatr Child Health       Date:  2002-01       Impact factor: 2.253

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.